Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study

The condition commonly referred to as long coronavirus disease (COVID) is characterized by the continuation of symptoms, sometimes accompanied by new symptoms that persist after the resolution of acute coronavirus disease 2019 (COVID‐19). This observational cross‐sectional study investigated 332 pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical virology 2024-08, Vol.96 (8), p.e29828-n/a
Hauptverfasser: Galúcio, Vanessa Costa Alves, Menezes, Daniel Carvalho, Chaves, Elem Cristina Rodrigues, Berg, Ana Virgínia Soares, Lima, Patrícia Danielle Lima, Costa Vasconcelos, Pedro Fernando, Quaresma, Juarez Antônio Simões, Falcão, Luiz Fábio Magno
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 8
container_start_page e29828
container_title Journal of medical virology
container_volume 96
creator Galúcio, Vanessa Costa Alves
Menezes, Daniel Carvalho
Chaves, Elem Cristina Rodrigues
Berg, Ana Virgínia Soares
Lima, Patrícia Danielle Lima
Costa Vasconcelos, Pedro Fernando
Quaresma, Juarez Antônio Simões
Falcão, Luiz Fábio Magno
description The condition commonly referred to as long coronavirus disease (COVID) is characterized by the continuation of symptoms, sometimes accompanied by new symptoms that persist after the resolution of acute coronavirus disease 2019 (COVID‐19). This observational cross‐sectional study investigated 332 patients with long COVID in the Brazilian Amazon region. The study aimed to elucidate the systemic interactions associated with long COVID by compiling the findings related to hematological, coagulation, immunological, metabolic, hepatic, renal, and muscular profiles. Participants with long COVID were identified using rigorous criteria and underwent thorough laboratory examinations. The obtained data were subsequently analyzed, allowing for comparisons, associations, and correlations between findings within distinct groups in the study. Significant associations were observed between hospitalization during the acute phase and persistent laboratory abnormalities, suggesting a potential link between acute severity and long‐term effects. Notably, individuals with long COVID for over a year exhibited elevated levels of monocytes, prolonged prothrombin times, reduced prothrombin activity, high levels of lactate dehydrogenase, and an increased frequency of qualitative C‐reactive protein detection. This study provides valuable insights into the laboratory risk profile of patients with long COVID, particularly in the unique context of the Amazon region, where patients exhibit persistent symptoms lasting up to 1261 days.
doi_str_mv 10.1002/jmv.29828
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3086381661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3086381661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2788-cc5fb72da8f55aac99d85c7c63b7be746aa018fc5915aaa40e2ed1f4f0413da83</originalsourceid><addsrcrecordid>eNp10btOwzAUBmALgWgpDLwAssQCQ4qdq81Wyq2oqAt0jRzHbl0lcbETqnbiEXhGngT3AgMSk6Xjz798zgHgFKMuRsi_mpXvXZ8Sn-yBNkY09ihK8D5oIxzGXhzjqAWOrJ0hhAj1_UPQCigiGIdRG8yGLNOG1dos4dxoqQpVTaCWcM5qJarawoWqp7DQrtofjQe3UFWwngp4Y9jKYVbBXslWuoJGTJSurmEPcqOt_fr4tILXrsQKaOsmXx6DA8kKK052Zwe83t-99B-94ehh0O8NPe4nhHicRzJL_JwRGUWMcUpzEvGEx0GWZCIJY8YQJpJHFLtrFiLhixzLUKIQB-5V0AEX21zXz1sjbJ2WynJRFKwSurFpgEgcEOzm4uj5HzrTjXE_XiuaxJiigDp1uVWbxoyQ6dyokpllilG6XkDqFpBuFuDs2S6xyUqR_8qfiTtwtQULVYjl_0np0_N4G_kN6ViRJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3097619039</pqid></control><display><type>article</type><title>Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Galúcio, Vanessa Costa Alves ; Menezes, Daniel Carvalho ; Chaves, Elem Cristina Rodrigues ; Berg, Ana Virgínia Soares ; Lima, Patrícia Danielle Lima ; Costa Vasconcelos, Pedro Fernando ; Quaresma, Juarez Antônio Simões ; Falcão, Luiz Fábio Magno</creator><creatorcontrib>Galúcio, Vanessa Costa Alves ; Menezes, Daniel Carvalho ; Chaves, Elem Cristina Rodrigues ; Berg, Ana Virgínia Soares ; Lima, Patrícia Danielle Lima ; Costa Vasconcelos, Pedro Fernando ; Quaresma, Juarez Antônio Simões ; Falcão, Luiz Fábio Magno</creatorcontrib><description>The condition commonly referred to as long coronavirus disease (COVID) is characterized by the continuation of symptoms, sometimes accompanied by new symptoms that persist after the resolution of acute coronavirus disease 2019 (COVID‐19). This observational cross‐sectional study investigated 332 patients with long COVID in the Brazilian Amazon region. The study aimed to elucidate the systemic interactions associated with long COVID by compiling the findings related to hematological, coagulation, immunological, metabolic, hepatic, renal, and muscular profiles. Participants with long COVID were identified using rigorous criteria and underwent thorough laboratory examinations. The obtained data were subsequently analyzed, allowing for comparisons, associations, and correlations between findings within distinct groups in the study. Significant associations were observed between hospitalization during the acute phase and persistent laboratory abnormalities, suggesting a potential link between acute severity and long‐term effects. Notably, individuals with long COVID for over a year exhibited elevated levels of monocytes, prolonged prothrombin times, reduced prothrombin activity, high levels of lactate dehydrogenase, and an increased frequency of qualitative C‐reactive protein detection. This study provides valuable insights into the laboratory risk profile of patients with long COVID, particularly in the unique context of the Amazon region, where patients exhibit persistent symptoms lasting up to 1261 days.</description><identifier>ISSN: 0146-6615</identifier><identifier>ISSN: 1096-9071</identifier><identifier>EISSN: 1096-9071</identifier><identifier>DOI: 10.1002/jmv.29828</identifier><identifier>PMID: 39081145</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Abnormalities ; Adult ; Aged ; Aged, 80 and over ; biomarkers ; Brazil - epidemiology ; C-Reactive Protein - analysis ; Coagulation ; Coronaviruses ; COVID-19 ; COVID-19 - blood ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; Cross-Sectional Studies ; Female ; hematological tests ; Hospitalization - statistics &amp; numerical data ; Humans ; Immunology ; L-Lactate dehydrogenase ; Laboratories ; laboratory markers ; Lactate dehydrogenase ; Long COVID ; Male ; Middle Aged ; Monocytes ; Prothrombin ; Qualitative analysis ; SARS-CoV-2 ; Signs and symptoms ; Viral diseases</subject><ispartof>Journal of medical virology, 2024-08, Vol.96 (8), p.e29828-n/a</ispartof><rights>2024 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2788-cc5fb72da8f55aac99d85c7c63b7be746aa018fc5915aaa40e2ed1f4f0413da83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmv.29828$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmv.29828$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39081145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Galúcio, Vanessa Costa Alves</creatorcontrib><creatorcontrib>Menezes, Daniel Carvalho</creatorcontrib><creatorcontrib>Chaves, Elem Cristina Rodrigues</creatorcontrib><creatorcontrib>Berg, Ana Virgínia Soares</creatorcontrib><creatorcontrib>Lima, Patrícia Danielle Lima</creatorcontrib><creatorcontrib>Costa Vasconcelos, Pedro Fernando</creatorcontrib><creatorcontrib>Quaresma, Juarez Antônio Simões</creatorcontrib><creatorcontrib>Falcão, Luiz Fábio Magno</creatorcontrib><title>Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study</title><title>Journal of medical virology</title><addtitle>J Med Virol</addtitle><description>The condition commonly referred to as long coronavirus disease (COVID) is characterized by the continuation of symptoms, sometimes accompanied by new symptoms that persist after the resolution of acute coronavirus disease 2019 (COVID‐19). This observational cross‐sectional study investigated 332 patients with long COVID in the Brazilian Amazon region. The study aimed to elucidate the systemic interactions associated with long COVID by compiling the findings related to hematological, coagulation, immunological, metabolic, hepatic, renal, and muscular profiles. Participants with long COVID were identified using rigorous criteria and underwent thorough laboratory examinations. The obtained data were subsequently analyzed, allowing for comparisons, associations, and correlations between findings within distinct groups in the study. Significant associations were observed between hospitalization during the acute phase and persistent laboratory abnormalities, suggesting a potential link between acute severity and long‐term effects. Notably, individuals with long COVID for over a year exhibited elevated levels of monocytes, prolonged prothrombin times, reduced prothrombin activity, high levels of lactate dehydrogenase, and an increased frequency of qualitative C‐reactive protein detection. This study provides valuable insights into the laboratory risk profile of patients with long COVID, particularly in the unique context of the Amazon region, where patients exhibit persistent symptoms lasting up to 1261 days.</description><subject>Abnormalities</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>biomarkers</subject><subject>Brazil - epidemiology</subject><subject>C-Reactive Protein - analysis</subject><subject>Coagulation</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - blood</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>Cross-Sectional Studies</subject><subject>Female</subject><subject>hematological tests</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Immunology</subject><subject>L-Lactate dehydrogenase</subject><subject>Laboratories</subject><subject>laboratory markers</subject><subject>Lactate dehydrogenase</subject><subject>Long COVID</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Monocytes</subject><subject>Prothrombin</subject><subject>Qualitative analysis</subject><subject>SARS-CoV-2</subject><subject>Signs and symptoms</subject><subject>Viral diseases</subject><issn>0146-6615</issn><issn>1096-9071</issn><issn>1096-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10btOwzAUBmALgWgpDLwAssQCQ4qdq81Wyq2oqAt0jRzHbl0lcbETqnbiEXhGngT3AgMSk6Xjz798zgHgFKMuRsi_mpXvXZ8Sn-yBNkY09ihK8D5oIxzGXhzjqAWOrJ0hhAj1_UPQCigiGIdRG8yGLNOG1dos4dxoqQpVTaCWcM5qJarawoWqp7DQrtofjQe3UFWwngp4Y9jKYVbBXslWuoJGTJSurmEPcqOt_fr4tILXrsQKaOsmXx6DA8kKK052Zwe83t-99B-94ehh0O8NPe4nhHicRzJL_JwRGUWMcUpzEvGEx0GWZCIJY8YQJpJHFLtrFiLhixzLUKIQB-5V0AEX21zXz1sjbJ2WynJRFKwSurFpgEgcEOzm4uj5HzrTjXE_XiuaxJiigDp1uVWbxoyQ6dyokpllilG6XkDqFpBuFuDs2S6xyUqR_8qfiTtwtQULVYjl_0np0_N4G_kN6ViRJA</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Galúcio, Vanessa Costa Alves</creator><creator>Menezes, Daniel Carvalho</creator><creator>Chaves, Elem Cristina Rodrigues</creator><creator>Berg, Ana Virgínia Soares</creator><creator>Lima, Patrícia Danielle Lima</creator><creator>Costa Vasconcelos, Pedro Fernando</creator><creator>Quaresma, Juarez Antônio Simões</creator><creator>Falcão, Luiz Fábio Magno</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>202408</creationdate><title>Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study</title><author>Galúcio, Vanessa Costa Alves ; Menezes, Daniel Carvalho ; Chaves, Elem Cristina Rodrigues ; Berg, Ana Virgínia Soares ; Lima, Patrícia Danielle Lima ; Costa Vasconcelos, Pedro Fernando ; Quaresma, Juarez Antônio Simões ; Falcão, Luiz Fábio Magno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2788-cc5fb72da8f55aac99d85c7c63b7be746aa018fc5915aaa40e2ed1f4f0413da83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abnormalities</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>biomarkers</topic><topic>Brazil - epidemiology</topic><topic>C-Reactive Protein - analysis</topic><topic>Coagulation</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - blood</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>Cross-Sectional Studies</topic><topic>Female</topic><topic>hematological tests</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Immunology</topic><topic>L-Lactate dehydrogenase</topic><topic>Laboratories</topic><topic>laboratory markers</topic><topic>Lactate dehydrogenase</topic><topic>Long COVID</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Monocytes</topic><topic>Prothrombin</topic><topic>Qualitative analysis</topic><topic>SARS-CoV-2</topic><topic>Signs and symptoms</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galúcio, Vanessa Costa Alves</creatorcontrib><creatorcontrib>Menezes, Daniel Carvalho</creatorcontrib><creatorcontrib>Chaves, Elem Cristina Rodrigues</creatorcontrib><creatorcontrib>Berg, Ana Virgínia Soares</creatorcontrib><creatorcontrib>Lima, Patrícia Danielle Lima</creatorcontrib><creatorcontrib>Costa Vasconcelos, Pedro Fernando</creatorcontrib><creatorcontrib>Quaresma, Juarez Antônio Simões</creatorcontrib><creatorcontrib>Falcão, Luiz Fábio Magno</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galúcio, Vanessa Costa Alves</au><au>Menezes, Daniel Carvalho</au><au>Chaves, Elem Cristina Rodrigues</au><au>Berg, Ana Virgínia Soares</au><au>Lima, Patrícia Danielle Lima</au><au>Costa Vasconcelos, Pedro Fernando</au><au>Quaresma, Juarez Antônio Simões</au><au>Falcão, Luiz Fábio Magno</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study</atitle><jtitle>Journal of medical virology</jtitle><addtitle>J Med Virol</addtitle><date>2024-08</date><risdate>2024</risdate><volume>96</volume><issue>8</issue><spage>e29828</spage><epage>n/a</epage><pages>e29828-n/a</pages><issn>0146-6615</issn><issn>1096-9071</issn><eissn>1096-9071</eissn><abstract>The condition commonly referred to as long coronavirus disease (COVID) is characterized by the continuation of symptoms, sometimes accompanied by new symptoms that persist after the resolution of acute coronavirus disease 2019 (COVID‐19). This observational cross‐sectional study investigated 332 patients with long COVID in the Brazilian Amazon region. The study aimed to elucidate the systemic interactions associated with long COVID by compiling the findings related to hematological, coagulation, immunological, metabolic, hepatic, renal, and muscular profiles. Participants with long COVID were identified using rigorous criteria and underwent thorough laboratory examinations. The obtained data were subsequently analyzed, allowing for comparisons, associations, and correlations between findings within distinct groups in the study. Significant associations were observed between hospitalization during the acute phase and persistent laboratory abnormalities, suggesting a potential link between acute severity and long‐term effects. Notably, individuals with long COVID for over a year exhibited elevated levels of monocytes, prolonged prothrombin times, reduced prothrombin activity, high levels of lactate dehydrogenase, and an increased frequency of qualitative C‐reactive protein detection. This study provides valuable insights into the laboratory risk profile of patients with long COVID, particularly in the unique context of the Amazon region, where patients exhibit persistent symptoms lasting up to 1261 days.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39081145</pmid><doi>10.1002/jmv.29828</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-6615
ispartof Journal of medical virology, 2024-08, Vol.96 (8), p.e29828-n/a
issn 0146-6615
1096-9071
1096-9071
language eng
recordid cdi_proquest_miscellaneous_3086381661
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Abnormalities
Adult
Aged
Aged, 80 and over
biomarkers
Brazil - epidemiology
C-Reactive Protein - analysis
Coagulation
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - diagnosis
COVID-19 - epidemiology
Cross-Sectional Studies
Female
hematological tests
Hospitalization - statistics & numerical data
Humans
Immunology
L-Lactate dehydrogenase
Laboratories
laboratory markers
Lactate dehydrogenase
Long COVID
Male
Middle Aged
Monocytes
Prothrombin
Qualitative analysis
SARS-CoV-2
Signs and symptoms
Viral diseases
title Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross‐sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A36%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laboratory%20profiling%20of%20patients%20with%20long%20COVID%20in%20the%20Brazilian%20Amazon%20region:%20A%20cross%E2%80%90sectional%20study&rft.jtitle=Journal%20of%20medical%20virology&rft.au=Gal%C3%BAcio,%20Vanessa%20Costa%20Alves&rft.date=2024-08&rft.volume=96&rft.issue=8&rft.spage=e29828&rft.epage=n/a&rft.pages=e29828-n/a&rft.issn=0146-6615&rft.eissn=1096-9071&rft_id=info:doi/10.1002/jmv.29828&rft_dat=%3Cproquest_cross%3E3086381661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3097619039&rft_id=info:pmid/39081145&rfr_iscdi=true